WANY
FLGT icon

Wealthspire Advisors (New York)’s Fulgent Genetics FLGT Stock Holding History

Wealthspire Advisors (New York)’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-65
Closed -$1.47K – 1680
2025
Q3 		$1.47K Buy
+65
New +$1.34K ﹤0.01% 2679
2025
Q1 		– Sell
-10,065
Closed -$186K – 805
2024
Q4 		$186K Buy
+10,065
New +$197K ﹤0.01% 752

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wealthspire Advisors (New York)'s FLGT Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Fulgent Genetics (FLGT) in Q4 2025, closing a stake of 65 shares — an estimated $1.47K sold.

Wealthspire Advisors (New York) first reported a position in FLGT in Q4 2024 and held it in 2 quarters. The position peaked at $186K in Q4 2024. 179 funds tracked by Wall St. Rank hold FLGT as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Fulgent Genetics position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 65 Fulgent Genetics shares in Q4 2025, an estimated $1.47K.
  • Wealthspire Advisors (New York) first reported a position in Fulgent Genetics in Q4 2024 and held it in 2 quarters.
  • Wealthspire Advisors (New York)'s Fulgent Genetics position peaked at $186K in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.